Three predictions for 2019: Reductions in list or Wholesale Acquisition Cost prices of a number of high-profile drugs, coupled with changes in the current rebate system; continued ascension of biosimilars, and; downward turn in the economy leading to a rise in the numbers of uninsured.
Looking Into A Crystal Ball: Some Healthcare Predictions For 2019
